Holen Sie sich die Stockscreener-App
17.12
3.87%
-0.69
Handel nachbörslich:
17.20
0.08
+0.47%
Erasca Inc Aktie (ERAS) Neueste Nachrichten
Erasca (ERAS) Among the Best Performing Stocks of Q1 2026 to Watch for Q2 - Yahoo Finance
JPMorgan Chase & Co. Has $2.77 Million Stock Holdings in Erasca, Inc. $ERAS - MarketBeat
5 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey
JPMorgan and Stifel Enhance Erasca’s Market Prospects with High Price Targets - timothysykes.com
Erasca CLO Ebun Garner sells $1.3m in ERAS stock By Investing.com - au.investing.com
Insider Selling: Erasca (NASDAQ:ERAS) Insider Sells 80,000 Shares of Stock - MarketBeat
Erasca CLO Ebun Garner sells $1.3m in ERAS stock - Investing.com
Erasca (ERAS) Chief Legal Officer exercises options, sells 80K shares under 10b5-1 plan - stocktitan.net
Erasca (NASDAQ:ERAS) Trading 8.2% HigherHere's What Happened - MarketBeat
Erasca Inc stock hits 52-week high at $14.63 - investing.com
Erasca Inc stock hits 52-week high at 16.41 USD By Investing.com - Investing.com South Africa
Erasca reports proposed 80,000-share sale (NASDAQ: ERAS) - stocktitan.net
Erasca (NASDAQ:ERAS) Hits New 1-Year HighShould You Buy? - marketbeat.com
Erasca Inc stock hits 52-week high at 16.41 USD - Investing.com
IBRX stock notches strongest quarter ever — but these 2 smaller biotech plays ran even hotter - MSN
ERAS Technical Analysis & Stock Price Forecast - Intellectia AI
Revenue Check: How does Erasca Inc perform in inflationary periods2026 Institutional & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Erasca (ERAS) price target increased by 42.72% to 14.99 - msn.com
Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't - Yahoo Finance
Erasca (NASDAQ:ERAS) Shares Up 8.8%Should You Buy? - MarketBeat
Erasca’s Stock Surges Higher Amid Pipeline Optimism - StocksToTrade
Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007 - TipRanks
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Erasca (ERAS) adds 13%; soars 310% YTD - MSN
Mizuho initiates Erasca (ERAS) with 'outperform' rating and $16 PT - msn.com
Assessing Erasca (ERAS) Valuation After ERAS-0015 Licensing Win And Data Anticipation - Yahoo Finance
Certain Stock Options of Erasca, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - MarketScreener
A Look At Erasca (ERAS) Valuation After Its Strong Recent Share Price Rally - simplywall.st
How Erasca’s Expanded ERAS-0015 License and Narrower 2025 Loss Will Impact Erasca (ERAS) Investors - simplywall.st
Erasca (ERAS) Adds 13%; Soars 310% YTD - Insider Monkey
5 Stocks Dominating Today’s Market Action - Insider Monkey
Erasca (NASDAQ:ERAS) Shares Up 10.3% on Better-Than-Expected Earnings - MarketBeat
Guggenheim more than doubles Erasca (ERAS) PT following clinical progress and updated pipeline models - MSN
ERAS Surges as JP Morgan Raises Price Target | ERAS Stock News - GuruFocus
JPMorgan Chase & Co. Increases Erasca (NASDAQ:ERAS) Price Target to $25.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS) - The Globe and Mail
Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Chipmakers Recap: Should I invest in Erasca Inc before earnings2026 Valuation Update & Weekly Sector Rotation Insights - baoquankhu1.vn
Erasca Form 144: Foundation Lists Proposed Common Sales | ERAS SEC FilingForm 144 - Stock Titan
Erasca (NASDAQ:ERAS) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Erasca’s Stock Faces Pressure as CMO Offloads Shares - StocksToTrade
uniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts - AOL.com
Erasca’s CMO Stock Sale Raises Eyebrows Amid Market Uncertainty - timothysykes.com
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):